United-Guardian Reports Second Quarter Results
Rhea-AI Summary
United-Guardian (NASDAQ: UG) reported higher results for the second quarter and first half of 2026. Q2 2026 net sales rose 10% year over year to $3,108,267, while net income increased 16% to $728,579, or $0.16 per share. For the six months ended June 30, 2026, net sales grew 12% to $5,980,489 and net income rose 30% to $1,547,481, or $0.34 per share.
According to United-Guardian, cosmetic ingredient sales increased 44% in Q2 and 34% in the first half, driven mainly by renewed purchasing from Ashland Specialty Ingredients. Pharmaceutical sales grew 1% in Q2 and 11% in the first half, led by Renacidin. Other income for the first half included $339,493 in settlement income and a $66,107 net gain on marketable securities.
Positive
- Q2 2026 net sales up 10% to $3.11 million year over year
- Q2 2026 net income up 16% to $728,579; EPS $0.16 vs. $0.14
- First-half 2026 net sales up 12% to $5.98 million vs. $5.32 million
- First-half 2026 net income up 30% to $1.55 million; EPS $0.34 vs. $0.26
- Cosmetic ingredient sales up 44% in Q2 and 34% in first half 2026
- Other income boosted by $339,493 settlement and $66,107 securities gain in first half 2026
Negative
- Cost of sales increased to $1.56 million in Q2 2026 from $1.34 million in Q2 2025
- First-half 2026 cost of sales rose to $3.01 million from $2.46 million year over year
- Income from operations grew more modestly to $754,125 in Q2 2026 from $695,453 in Q2 2025
- R&D expense increased to $124,395 in Q2 2026 and $239,416 for first half 2026 vs. 2025
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 08 | First quarter earnings | Positive | -1.9% | Sales and net income increased, but the stock declined 1.86% over 24 hours. |
| Mar 27 | Annual earnings report | Negative | +5.0% | Full-year sales and net income declined, while the stock gained 4.96%. |
| Nov 06 | Third quarter earnings | Negative | -6.3% | Nine-month sales and income declined, followed by a 6.29% stock decline. |
| Aug 08 | Second quarter earnings | Negative | -0.5% | Quarterly sales and income declined, followed by a 0.5% stock decline. |
| May 08 | First quarter earnings | Negative | +0.6% | Sales and net income declined, while the stock gained 0.61%. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior tag-specific earnings reactions were mixed, with 2 aligned events and 3 divergences relative to the announcements.
Key Terms
forward-looking statements regulatory
safe harbor regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
HAUPPAUGE, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2026. Second quarter net sales increased by
Donna Vigilante, President of United-Guardian, stated, “I am pleased to report that sales and earnings increased in both the second quarter and first half of 2026. Sales of our cosmetic ingredients and pharmaceutical products increased during both periods compared with the same periods in 2025. Cosmetic ingredient sales increased by
“As we move through 2026, we remain focused on our growth plan, which includes expanding promotional efforts and increasing market awareness for Renacidin, particularly among physicians and care providers; increasing awareness of our “natural” products; and growing our medical lubricant business.”
United-Guardian is a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients.
| Contact: | Donna Vigilante |
| (631) 273-0900 | |
| dvigilante@u-g.com |
NOTE: This press release contains both historical and "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company’s expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the “safe harbor” provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company’s business please refer to the company's reports and filings with the Securities and Exchange Commission.
| Financial Results for the Three and Six Months Ended June 30, 2026 and 2025 | ||||||||||||
| STATEMENTS OF INCOME (unaudited) | ||||||||||||
| THREE MONTHS ENDED JUNE 30, | SIX MONTHS ENDED JUNE 30, | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| Net sales | $ | 3,108,267 | $ | 2,838,225 | $ | 5,980,489 | $ | 5,319,352 | ||||
| Costs and expenses: | ||||||||||||
| Cost of sales | 1,562,465 | 1,340,854 | 3,010,254 | 2,463,930 | ||||||||
| Operating expenses | 667,282 | 694,050 | 1,334,245 | 1,326,785 | ||||||||
| Research and development expense | 124,395 | 107,868 | 239,416 | 222,262 | ||||||||
| Total costs and expenses | 2,354,142 | 2,142,772 | 4,583,915 | 4,012,977 | ||||||||
| Income from operations | 754,125 | 695,453 | 1,396,574 | 1,306,375 | ||||||||
| Other income: | ||||||||||||
| Investment income | 70,445 | 70,573 | 140,259 | 155,260 | ||||||||
| Net gain on marketable securities | 48,365 | 24,576 | 66,107 | 36,926 | ||||||||
| Settlement income | 36,360 | --- | 339,493 | --- | ||||||||
| Gain on sale of asset | 8,310 | --- | 8,310 | --- | ||||||||
| Total other income | 163,480 | 95,149 | 554,169 | 192,186 | ||||||||
| Income before provision for income taxes | 917,605 | 790,602 | 1,950,743 | 1,498,561 | ||||||||
| Provision for income taxes | 189,026 | 163,776 | 403,262 | 310,840 | ||||||||
| Net income | $ | 728,579 | $ | 626,826 | $ | 1,547,481 | $ | 1,187,721 | ||||
| Earnings per common share (basic and diluted) | $ | 0.16 | $ | 0.14 | $ | 0.34 | $ | 0.26 | ||||
| Weighted average shares (basic and diluted) | 4,594,319 | 4,594,319 | 4,594,319 | 4,594,319 | ||||||||
